KAUFMAN JONATHAN H (See Remarks) purchased 6.6% of their position (55K shares) of LIPELLA PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $45.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/19/2024ACC: 0001753926-24-000573
DirectorOfficer10% Owner· See Remarks
Since Dec 2022
+135K
Net shares
Net buyer
$45.5K
Total acquired
2
Open market trades
2B · 0S
3
Total transactions
135K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$0.79
Trade value
$23.65K
% of position
3.6%
3/18/2024
833.85K→863.85K
Common Stock
Direct
Shares
+25K
Price / share
$0.87
Trade value
$21.80K
% of position
2.9%
3/19/2024
863.85K→888.85K
Total
Net shares
+55K
Net value
$45.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2024 | P · Purchase | +30K | $0.79 | $23.65K | 3.6% | 833.85K | 863.85K |
| Common Stock Direct | 3/19/2024 | P · Purchase | +25K | $0.87 | $21.80K | 2.9% | 863.85K | 888.85K |
| Total | +55K | $45.45K | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Stock
80K shares
Shares
+80K
Strike price
0.77
Held after
80K
Exercisable
—
3/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock80K shares | 3/15/2024 | A · Award | +80K | 0.77 | — | 80K |